PULMONARY HYPERTENSION, PRIMARY, 4
|
disease |
|
Disease or Syndrome
|
1
|
7
|
0.600 |
None |
1.000 |
2 |
7
|
2013 |
2017 |
Disorder of pulmonary circulation
|
group |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Increased pulmonary vascular resistance
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
3
|
0.300 |
None |
|
0 |
|
|
|
Pulmonary Hypertension, Primary, Fenfluramine-Associated
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
|
0.300 |
None |
|
0 |
|
|
|
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
7
|
1
|
0.300 |
None |
|
0 |
|
|
|
PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
8
|
3
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Pulmonary Hypertension, Primary, 1
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
9
|
323
|
0.400 |
None |
|
0 |
1
|
|
|
Pulmonary Veno-Occlusive Disease (disorder)
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
11
|
1
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Familial pulmonary arterial hypertension
|
disease |
|
Disease or Syndrome
|
12
|
1
|
0.320 |
None |
1.000 |
3 |
|
2013 |
2017 |
cerebellar function
|
disease |
|
Disease or Syndrome
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
2-oxo-hept-3-ene-1,7-dioate hydratase activity
|
phenotype |
|
Molecular Function
|
14
|
|
0.300 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Potassium measurement
|
phenotype |
|
Laboratory Procedure
|
16
|
28
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Long QT Syndrome 1
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Disease or Syndrome
|
20
|
240
|
0.020 |
None |
1.000 |
2 |
|
1997 |
1998 |
Romano-Ward Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Disease or Syndrome
|
22
|
17
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Associated Pulmonary Arterial Hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
22
|
4
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Affective Symptoms
|
phenotype |
Behavior and Behavior Mechanisms
|
Sign or Symptom
|
23
|
10
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Familial primary pulmonary hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
30
|
2
|
0.640 |
strong |
1.000 |
7 |
|
2013 |
2019 |
Congenital long QT syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Disease or Syndrome
|
30
|
54
|
0.020 |
None |
1.000 |
2 |
|
2003 |
2005 |
Ph-Like Acute Lymphoblastic Leukemia
|
disease |
|
Neoplastic Process
|
30
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chronic atrial fibrillation
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
31
|
|
0.020 |
None |
1.000 |
2 |
|
2015 |
2017 |
Tuberculosis, Drug-Resistant
|
disease |
Infections
|
Disease or Syndrome
|
37
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Astrocytosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
37
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hereditary hemorrhagic telangiectasia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
42
|
81
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2018 |
Fenestration (morphologic abnormality)
|
disease |
|
Acquired Abnormality
|
43
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |